Moleculin Biotech, Inc. (MBRX) stock
MBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.83−0.31 (-4.34%)
Close on Nov 17, 2026Market cap $133.03MP/E –Yield –
Moleculin Biotech price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Moleculin Biotech's price to book ratio was 5.0× on Nov 11, 2026, against 17.8× a year earlier. Over the last 5 years it ranged from 2.8× to 23.6×, with a median of 9.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 5.0× | −7.9 |
| 2025 | Jul 31, 2025 | 12.9× | +7.0 |
| 2024 | Dec 31, 2024 | 5.9× | −8.7 |
| 2023 | Dec 29, 2023 | 14.6× | +4.2 |
| 2022 | Dec 30, 2022 | 10.4× | −2.7 |
| 2021 | Dec 31, 2021 | 13.1× | −55.0 |
| 2020 | Dec 31, 2020 | 68.1× | +24.0 |
| 2019 | Dec 31, 2019 | 44.1× | +6.8 |
| 2018 | Dec 31, 2018 | 37.3× | −4.2 |
| 2017 | Dec 29, 2017 | 41.5× | +7.7 |
| 2016 | Dec 30, 2016 | 33.8× | – |
See a number that looks wrong?